Europe — EMA
Omvoh (Mirikizumab)
Mirikizumab, the active ingredient in Omvo, is a monoclonal antibody presented as a solution for intravenous infusion use. It targets inflammatory pathways and is being investigated for chronic inflammatory diseases in…
Request sourcing
What is Mirikizumab?
Mirikizumab, the active ingredient in Omvo, is a monoclonal antibody presented as a solution for intravenous infusion use. It targets inflammatory pathways and is being investigated for chronic inflammatory diseases in adult patients. GNH USA supplies Omvo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.
GNH USA supplies Omvo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.
What is Mirikizumab used for?
Omvo is a biologic therapy that modulates the ... - Ulcerative colitis: It ... ... .... .... - Cro ... .... ... ... .... .... ... - P… .... … ...
What are the side effects of Mirikizumab?
Common ... … ....
